Sundrug Co Ltd
TSE:9989
Sundrug Co Ltd
Cost of Revenue
Sundrug Co Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sundrug Co Ltd
TSE:9989
|
Cost of Revenue
-¥550B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
Tsuruha Holdings Inc
TSE:3391
|
Cost of Revenue
-¥704.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-11%
|
|
Welcia Holdings Co Ltd
TSE:3141
|
Cost of Revenue
-¥847.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-13%
|
|
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Cost of Revenue
-¥515.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
MatsukiyoCocokara & Co
TSE:3088
|
Cost of Revenue
-¥668.4B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
Cosmos Pharmaceutical Corp
TSE:3349
|
Cost of Revenue
-¥752.6B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-10%
|
See Also
What is Sundrug Co Ltd's Cost of Revenue?
Cost of Revenue
-550B
JPY
Based on the financial report for Dec 31, 2023, Sundrug Co Ltd's Cost of Revenue amounts to -550B JPY.
What is Sundrug Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-5%
Over the last year, the Cost of Revenue growth was -8%. The average annual Cost of Revenue growth rates for Sundrug Co Ltd have been -5% over the past three years , -5% over the past five years , and -5% over the past ten years .